Language selection

Search

2012-09-05 - Female - 30 Years old

462613

Adverse reaction report number 462613
Latest AER version number 0
Market authorization holder AER number ALL1201203992
Initial received date 2012-09-05
Latest received date 2012-09-05
Age 30 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Consumer Or Other Non Health Professional
Source of report MAH
Report outcome Not recovered/not resolved
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 10MGCAPSULE, EXTENDED RELEASESuspectOral10 Milligram Attention deficit/hyperactivity disorder
ADDERALL XR 5MGCAPSULE, EXTENDED RELEASESuspectOral5 Milligram Attention deficit/hyperactivity disorder
SYNTHROIDNOT SPECIFIEDConcomitant

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug effect decreased
Incorrect dose administered
Insomnia
Date modified: